Vaccinex, Inc. Files 8-K Report
Ticker: VCNX · Form: 8-K · Filed: Aug 14, 2024 · CIK: 1205922
| Field | Detail |
|---|---|
| Company | Vaccinex, Inc. (VCNX) |
| Form Type | 8-K |
| Filed Date | Aug 14, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials, filing
TL;DR
Vaccinex filed an 8-K, standard disclosure stuff.
AI Summary
On August 14, 2024, Vaccinex, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Vaccinex, Inc. is providing updated disclosures and financial information to the SEC, which is standard practice for public companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosure and exhibits, not indicating any immediate negative or positive material event.
Key Numbers
- 001-38624 — Commission File Number (Identifies the company's SEC filing history)
- 16-1603202 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Vaccinex, Inc. (company) — Registrant
- August 14, 2024 (date) — Date of earliest event reported
- 1895 Mount Hope Avenue, Rochester, New York 14620 (location) — Principal executive offices address
FAQ
What is the primary purpose of this 8-K filing by Vaccinex, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to include Financial Statements and Exhibits.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on August 14, 2024.
What is Vaccinex, Inc.'s principal executive office address?
Vaccinex, Inc.'s principal executive office is located at 1895 Mount Hope Avenue, Rochester, New York 14620.
What is Vaccinex, Inc.'s Commission File Number?
Vaccinex, Inc.'s Commission File Number is 001-38624.
What is Vaccinex, Inc.'s IRS Employer Identification Number?
Vaccinex, Inc.'s IRS Employer Identification Number is 16-1603202.
Filing Stats: 490 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-08-14 08:35:52
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VCNX Nasdaq Capital Marke
Filing Documents
- d838109d8k.htm (8-K) — 25KB
- d838109dex991.htm (EX-99.1) — 18KB
- g838109g0814090701390.jpg (GRAPHIC) — 33KB
- g838109g0814090701645.jpg (GRAPHIC) — 9KB
- g838109img01.jpg (GRAPHIC) — 6KB
- 0001193125-24-200272.txt ( ) — 231KB
- vcnx-20240814.xsd (EX-101.SCH) — 3KB
- vcnx-20240814_lab.xml (EX-101.LAB) — 17KB
- vcnx-20240814_pre.xml (EX-101.PRE) — 11KB
- d838109d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated August 14, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VACCINEX, INC. Date: August 14, 2024 By: /s/ Jill Sanchez Jill Sanchez Chief Financial Officer